solid

Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors

July 02, 2025 06:00 ET  | Source: Instil Bio US phase 1 trial of ‘2510 is expected to be initiated before…

3 months ago

KBRA Affirms and Withdraws Rating for Fortegra Financial Corp, Assigns Ratings for The Fortegra Group, Inc., and Fortegra Specialty Insurance Company, and Affirms Ratings for Debt and Fortegra’s Key Insurance Subsidiaries

NEW YORK--(BUSINESS WIRE)--#creditratingagency--KBRA assigns an issuer rating of BBB to The Fortegra Group, Inc. (TFG or Fortegra) and assigns an…

4 months ago
Show previous Posts